Related references
Note: Only part of the references are listed.Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1β triggers reactivation of latent cytomegalovirus in immunocompetent mice
Charles H. Cook et al.
JOURNAL OF VIROLOGY (2006)
Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients
J. A. Khoury et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection
T Reischig et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation
U Sester et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Cytomegalovirus enhance expression of growth factors during the development of chronic allograft nephropathy in rats
K Inkinen et al.
TRANSPLANT INTERNATIONAL (2005)
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
C Paya et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
S Sagedal et al.
KIDNEY INTERNATIONAL (2004)
The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models
E Kudlacz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis
E Akalin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
The association of cytomegalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis
MA Schnitzler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: The importance of HLA-DR matching
MA Schnitzler et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
CMV increases TNF-α expression in a rat kidney model of chronic rejection
L Krogerus et al.
TRANSPLANTATION PROCEEDINGS (2003)
Cytomegalovirus increases collagen synthesis in chronic rejection in the rat
K Inkinen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Definitions of cytomegalovirus infection and disease in transplant recipients
P Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts
RR Razonable et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir
RR Razonable et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
CMV accelerates tubular apoptosis in a model of chronic renal allograft rejection
L Krogerus et al.
TRANSPLANTATION PROCEEDINGS (2001)
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants
AP Limaye et al.
LANCET (2000)
Share Paper
